KD Logo

Analysts review Nurix Therapeutics Inc’s rating

Nurix Therapeutics Inc’s recently made public that its Chief Financial Officer van Houte Hans unloaded Company’s shares for reported $68223.0 on Feb 16 ’24. In the deal valued at $10.02 per share,6,812 shares were sold. As a result of this transaction, van Houte Hans now holds 68,333 shares worth roughly $0.85 million.

Then, Hansen Gwenn sold 2,334 shares, generating $18,649 in total proceeds. Upon selling the shares at $7.99, the Chief Scientific Officer now owns 36,402 shares.

Before that, Ring Christine sold 1,760 shares. Nurix Therapeutics Inc shares valued at $14,063 were divested by the Chief Legal Officer at a price of $7.99 per share. As a result of the transaction, Ring Christine now holds 17,427 shares, worth roughly $0.22 million.

A number of analysts have revised their coverage, including Barclays’s analysts, who began to cover the stock in early March with a ‘”an Overweight”‘ rating. Oppenheimer began covering NRIX with “an Outperform” recommendation on February 28, 2023. Morgan Stanley started covering the stock on October 11, 2022. It rated NRIX as “an Equal-weight”.

Price Performance Review of NRIX

On Monday, Nurix Therapeutics Inc [NASDAQ:NRIX] saw its stock jump 0.89% to $12.47. Over the last five days, the stock has lost -8.17%. Nurix Therapeutics Inc shares have risen nearly 20.83% since the year began. Nevertheless, the stocks have risen 29.63% over the past one year. While a 52-week high of $18.12 was reached on 04/11/24, a 52-week low of $4.22 was recorded on 01/29/24. SMA at 50 days reached $13.57, while 200 days put it at $9.44. A total of 1.13 million shares were traded, compared to the trading of 0.52 million shares in the previous session.

Levels Of Support And Resistance For NRIX Stock

The 24-hour chart illustrates a support level at 12.23, which if violated will result in even more drops to 12.00. On the upside, there is a resistance level at 12.84. A further resistance level may holdings at 13.22. The Relative Strength Index (RSI) on the 14-day chart is 41.65, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.93, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 94.96%. Stochastics %K at 3.26% indicates the stock is a buying.

Most Popular

[the_ad id="945"]